HCP Connect Contributor
Dr. Aditi Kulkarni
Dr. Aditi Kulkarni contributes neurology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.
Recent Drug Updates
21 total
Neurology
FDA Approves Lecanemab for Alzheimer: 27% Cognitive Decline Reduction
FDA approves lecanemab for Alzheimer: 27% cognitive decline reduction in early-stage patients, highlighting new treatment options.
Neurology
FDA Approves Lecanemab for Alzheimer: Biweekly IV vs Weekly Subcutaneous Administration
FDA approves lecanemab for Alzheimer: biweekly IV vs weekly subcutaneous administration options.
Neurology
FDA Approves Tolbrutinib for Progressive MS: New BTK Inhibitor in Treatment Algorithm
FDA approves tolbrutinib for progressive MS, offering a new BTK inhibitor option for treatment.
Neurology
CGRP Inhibitors for Migraine Prevention: Comparing Erenumab, Fremanezumab, Atogepant, and Rimegepant
CGRP inhibitors for migraine prevention: comparing erenumab, fremanezumab, atogepant, and rimegepant for optimal patient outcomes.
Neurology
FDA Approves Lecanemab Subcutaneous Autoinjector for Alzheimer: Weekly Home Administration vs Biweekly IV
Lecanemab subcutaneous autoinjector approved for Alzheimer's: weekly home administration vs biweekly IV.
Neurology
FDA Approves Efgartigimod for Myasthenia Gravis: Novel Treatment Algorithm for Seronegative Cases
Efgartigimod offers a new treatment algorithm for myasthenia gravis, reducing IgG levels and improving patient outcomes.
Neurology
FDA Approves Efgartigimod for Myasthenia Gravis: New Subcutaneous Formulation Enhances Patient Access
Efgartigimod approved for myasthenia gravis: new subcutaneous formulation enhances patient access and adherence.
Neurology
FDA Approves Lecanemab for Alzheimer: Weekly Dosing Option Now Available
FDA approves lecanemab for Alzheimer: weekly dosing option now available for home administration.
Neurology
FDA Grants Priority Review for Weekly Subcutaneous Lecanemab in Alzheimer’s Disease
FDA grants priority review for weekly subcutaneous lecanemab in Alzheimer’s disease, enhancing treatment accessibility.
Neurology
FDA Approves Copper Histidinate for Menkes Disease: 78% Reduction in Mortality Risk
FDA approves copper histidinate for Menkes disease: 78% reduction in mortality risk for pediatric patients.
Neurology
CGRP Inhibitors: Erenumab, Fremanezumab, and Galcanezumab for Migraine Prevention
CGRP inhibitors erenumab, fremanezumab, and galcanezumab reduce migraine frequency, offering new prevention options.
Neurology
FDA Approves Zycubo for Menkes Disease: 78% Reduction in Mortality Risk
FDA approves Zycubo for Menkes disease: 78% reduction in mortality risk in pediatric patients.
Neurology
FDA Approves Donanemab for Alzheimer: 27% Cognitive Decline Reduction
FDA approves donanemab for Alzheimer: 27% cognitive decline reduction in mild AD patients.
Neurology
FDA Approves Atogepant for Episodic Migraine Prevention: 50% Reduction in Monthly Migraine Days
Atogepant (Qulipta) approved for episodic migraine prevention: 50% reduction in monthly migraine days.
Medical Research
Type 2 Diabetes Linked to Faster Chronic Disease Onset
New research reveals type 2 diabetes accelerates development of multiple chronic diseases, particularly in middle-aged adults, impacting patient outcomes and treatment plans.
Medical Research
Emotional Eaters Less Likely to Lose Weight on GLP-1 Therapy
Research reveals individuals who overeat for emotional reasons may have reduced weight loss success with GLP-1 receptor agonists like Ozempic.
Healthcare Business
Reduce Mental Fatigue in Hearing Loss Patients by 30%
Discover how addressing hearing loss can improve mental health outcomes, reducing social isolation, anxiety, and depression in patients.
Neurology
Boost Neurology Dept Efficiency with Effective Vice Chair Roles
Discover how evolving vice chair responsibilities can enhance neurology department leadership, faculty engagement, and alignment with institutional goals.
Health Information
Accurate RA Diagnosis in Less Time
Learn how lab tests and imaging help doctors diagnose rheumatoid arthritis quickly and accurately, reducing diagnostic time and improving patient outcomes.
Medical Devices
Boost Breast Cancer Survival Rates with Latest Treatments
Discover how advances in breast cancer treatment are improving patient outcomes and survival rates, offering new hope for individuals diagnosed with the disease.
Medical Research
FDA May Drop Expert Reviews, Impacting Drug Approval
Proposed FDA policy change could reduce public scrutiny of new drug approvals, what it means for physicians and patient care decisions.